Genolution Inc. (KOSDAQ:225220)
South Korea
· Delayed Price · Currency is KRW 2,045.00
-60.00 (-2.85%)
At close: Dec 5, 2025
Genolution Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Operating Revenue | 9,146 | 7,136 | 9,761 | 38,085 |
| Other Revenue | -0 | -0 | - | -0 |
| Revenue | 9,146 | 7,136 | 9,761 | 38,085 |
| Revenue Growth (YoY) | 25.57% | -26.90% | -74.37% | - |
| Cost of Revenue | 5,119 | 4,836 | 5,304 | 12,177 |
| Gross Profit | 4,027 | 2,300 | 4,457 | 25,907 |
| Selling, General & Admin | 9,872 | 7,940 | 7,142 | 8,660 |
| Research & Development | 608.61 | 1,672 | 3,081 | 1,516 |
| Amortization of Goodwill & Intangibles | 47.24 | 42.79 | 32.16 | 22.38 |
| Other Operating Expenses | 275.13 | 252.32 | 330.46 | -18.12 |
| Operating Expenses | 12,724 | 11,464 | 11,549 | 11,171 |
| Operating Income | -8,697 | -9,164 | -7,091 | 14,737 |
| Interest Expense | -828.09 | -418.09 | - | -311.61 |
| Interest & Investment Income | 1,258 | 1,808 | 1,835 | 665.52 |
| Earnings From Equity Investments | - | -103.43 | 382.21 | -144.85 |
| Currency Exchange Gain (Loss) | 1,981 | 4,114 | 377.64 | 1,703 |
| Other Non Operating Income (Expenses) | 103.57 | 126.9 | 19.02 | 568.26 |
| EBT Excluding Unusual Items | -6,182 | -3,637 | -4,477 | 17,217 |
| Gain (Loss) on Sale of Investments | -2,837 | -3,118 | 542.13 | -459.01 |
| Gain (Loss) on Sale of Assets | -26.05 | - | -2,577 | 218.54 |
| Asset Writedown | -25 | -17 | -141.55 | - |
| Other Unusual Items | - | - | - | 262.4 |
| Pretax Income | -9,070 | -6,771 | -6,653 | 17,239 |
| Income Tax Expense | -245.54 | 437.36 | -1,103 | 2,637 |
| Earnings From Continuing Operations | -8,825 | -7,209 | -5,550 | 14,602 |
| Minority Interest in Earnings | 765.96 | 383.22 | 38.75 | - |
| Net Income | -8,059 | -6,826 | -5,512 | 14,602 |
| Net Income to Common | -8,059 | -6,826 | -5,512 | 14,602 |
| Shares Outstanding (Basic) | 18 | 18 | 18 | 18 |
| Shares Outstanding (Diluted) | 18 | 18 | 18 | 19 |
| Shares Change (YoY) | -0.04% | -1.58% | -2.81% | - |
| EPS (Basic) | -446.09 | -378.02 | -300.43 | 800.93 |
| EPS (Diluted) | -446.09 | -378.02 | -300.43 | 768.91 |
| Free Cash Flow | -8,434 | -13,558 | -7,940 | -8,955 |
| Free Cash Flow Per Share | -466.85 | -750.87 | -432.81 | -474.38 |
| Gross Margin | 44.03% | 32.23% | 45.66% | 68.03% |
| Operating Margin | -95.09% | -128.42% | -72.65% | 38.70% |
| Profit Margin | -88.12% | -95.65% | -56.46% | 38.34% |
| Free Cash Flow Margin | -92.22% | -190.00% | -81.34% | -23.51% |
| EBITDA | -6,281 | -7,123 | -5,513 | 16,065 |
| EBITDA Margin | -68.67% | -99.82% | -56.48% | 42.18% |
| D&A For EBITDA | 2,416 | 2,041 | 1,578 | 1,328 |
| EBIT | -8,697 | -9,164 | -7,091 | 14,737 |
| EBIT Margin | -95.09% | -128.42% | -72.65% | 38.70% |
| Effective Tax Rate | - | - | - | 15.30% |
| Advertising Expenses | - | 470.47 | 343.49 | 435.03 |
Source: S&P Capital IQ. Standard template. Financial Sources.